Ardsley Advisory Partners LP Aldeyra Therapeutics, Inc. Call Options Transaction History
Ardsley Advisory Partners LP
- $610 Million
- Q2 2025
Call Options
2 transactions
Others Institutions Holding ALDX
# of Institutions
136Shares Held
34.9MCall Options Held
263KPut Options Held
51.6K-
Knoll Capital Management, LLC Miami, FL5.48MShares$29.3 Million14.27% of portfolio
-
Perceptive Advisors LLC New York, NY4.05MShares$21.7 Million0.68% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.5MShares$18.8 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.47MShares$7.9 Million0.0% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $313M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...